Ahlskog JE. Parkinson's disease treatment guide for physicians.Oxford: Oxford University Press; 2009

Care Quality Commission. Experts by experience. 2022. (accessed 25 July 2023)

Improving timely medicines administration to Parkinson's patients in the inpatient setting. 2020. (accessed 25 July 2023)

What is dopamine?. 2021. (accessed 25 July 2023)

Department of Health and Social Care. The NHS Constitution for England. 2021. (accessed 25 July 2023)

Donizak J, McCabe C. Pharmacological management of patients with Parkinson's disease in the acute hospital setting: a review. British Journal of Neuroscience Nursing. 2017; 13:(5)220-225

Gerlach OHH, Broen MPG, van Domburg PHMF, Vermeij AJ, Weber WEJ. Deterioration of Parkinson's disease during hospitalization: survey of 684 patients. BMC Neurol. 2012; 12:(1)

Gerlach OHH, Winogrodzka A, Weber WEJ. Clinical problems in the hospitalized Parkinson's disease patient: systematic review. Mov Disord. 2011; 26:(2)197-208

Goetz CG. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011; 1:(1)

Grissinger M. Delayed administration and contraindicated drugs place hospitalized Parkinson's disease patients at risk. Pharmacy and Therapeutics. 2018; 43:(1)10-39

Hou JG, Wu LJ, Moore S Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012; 18:(4)377-381

Parkinson's disease medication. 2016. (accessed 25 July 2023)

Kumar R. Research methodology a step-by-step guide for beginners, 5th edn. London: SAGE Publications; 2019

Lance S, Travers J, Bourke D. Reducing medication errors for hospital inpatients with Parkinsonism. Intern Med J. 2021; 51:(3)385-389

Moule P. Making sense of research in nursing, health and social care, 6th edn. London: Sage Publications; 2018

Nance MA, Boettcher L, Edinger G Quality improvement in Parkinson's disease: a successful program to enhance timely administration of levodopa in the hospital. J Parkinsons Dis. 2020; 10:(4)1551-1559

National Institute for Health and Care Excellence. Parkinson's disease in adults. NICE guideline NG71. 2017. (accessed 25 July 2023)

National Institute for Health and Care Excellence. Parkinson's disease. Quality standard QS164. 2018. (accessed 25 July 2023)

National Institute for Health and Care Excellence. Parkinson's disease: how common is it? Clinical knowledge summary. 2022. (accessed 25 July 2023)

NHS website. Treatment: Parkinson's disease. 2022. (accessed 25 July 2023)

Okunoye O, Horsfall L, Marston L, Walters K, Schrag A. Rate of hospitalizations and underlying reasons among people with Parkinson's disease: population-based cohort study in UK primary care. J Parkinsons Dis. 2022; 12:(1)411-420

O'Leary Z. The essential guide to doing your research project, 2nd edn. London: SAGE Publications; 2014

Omeni E, Barnes M, MacDonald D, Crawford M, Rose D. Service user involvement: impact and participation: a survey of service user and staff perspectives. BMC Health Serv Res. 2014; 14:(1)

Parahoo K. Nursing research: principles, process and issues, 3rd edn. London: Palgrave Macmillan; 2014

Parkinson's UK. The incidence and prevalence of Parkinson's in the UK. 2017. (accessed 25 July 2023)

Parkinson's UK. The incidence and prevalence of Parkinson's in the UK. 2018. (accessed 25 July 2023)

Parkinson's UK. 2015-19 Strategy results. 2020. (accessed 25 July 2023)

Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice, 10th edn. Baltimore (MD): Wolter Kluwer; 2022

Skelly R, Brown L, Fakis A, Walker R. Hospitalization in Parkinson's disease: a survey of UK neurologists, geriatricians and Parkinson's disease nurse specialists. Parkinsonism Relat Disord. 2015; 21:(3)277-281

Skelly R, Brown L, Fogarty A. Delayed administration of dopaminergic drugs is not associated with prolonged length of stay of hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2017; 35:25-29

Importance of timely administration of dopaminergic medications to improve Parkinson's patients' clinical outcomes

17 August 2023
Volume 32 · Issue 15


This article explores the challenges posed when ensuring the effective management of patients with Parkinson's in the secondary care setting. The evidence base around the appropriate timing and administration of medications is explored and highlights key themes in the literature to support best practice and raise clinical awareness. Failure to follow prescribed treatments for patients with Parkinson's can have significant implications for both patients and nursing care.

This article explores the implications of caring for patients with Parkinson's in secondary care. The evidence base is explored within the article to establish key considerations for the role of the nurse and to highlight risks associated with improper administration of time-critical medications.

Parkinson's was first described as the ‘shaking palsy’ and in the 1870s was named Parkinson's in honour of James Parkinson who was responsible for distinguishing Parkinson's from other diseases exhibiting similar symptoms (Goetz, 2011). According to the National Institute for Health and Care Excellence (NICE) (2017), there are no reliable tests that can distinguish Parkinson's from other diseases exhibiting similar symptoms, and its diagnosis is based upon clinical history and examination. Parkinson's is the second most common neurodegenerative disorder after Alzheimer's (Gerlach et al, 2011).

Dopamine is a chemical produced by neurons and is a type of neurotransmitter. The nervous system uses it to communicate between nerve cells to control movement, and it plays a role in the ability to think and plan (Cristol, 2021). Subsequently, the development of Parkinson's is related to the cell death of these neurons, causing a resting tremor, bradykinesia, rigidity, postural instability and swallowing difficulties (Ahlskog, 2009). Although Parkinson's is typically a slow progressive disorder, it does have a huge impact on patients' abilities and quality of life (Houghton et al, 2016). Currently, Parkinson's is regarded as idiopathic as its cause is unknown (Ahlskog, 2009). Donizak and McCabe (2017) highlighted that most people with Parkinson's first develop symptoms at around 60 years of age, suggesting that the disease primarily arises with increased age and longevity.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content